RxDoctor Payments Data

Aaron Thrasher, PA

Physician Assistant · Anchorage, AKNPI 1245610955

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Nevro Corp. at 54.7% of the total. Reporting peaked in 2023 at $1,048 and has fallen 70.9% since, to $305 in 2025.

$1,708in general payments, 2019–2025

Across 21 payments — averaging $81.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$934
  • Si-bone, Inc.$367
  • Medtronic$194
  • Abbott$103
  • Baxter Healthcare$73
  • GT Medical Technologies, Inc$19
  • plus $18 from 1 others

What the payments were for

  • Speaking & faculty fees$20712%
  • Travel & lodging$63137%
  • Food & beverage$80747%
  • Education$634%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,708 in reported general payments places this provider in the 85th percentile of 365 physician assistant providers in Alaska.

See all physician assistant providers in Alaska

Medicare billing

Part B allowed, 2024
$51,901
Medicare patients
169
Services billed
455

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl24$184
Cyclobenzaprine Hcl27$184

Paid to pharmacies, not to this prescriber.

Other physician assistant in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →